Through its unique CORAL® platform for disease-focused therapeutic consortia design, optimization and manufacturing, MRM Health develops effective live bacterial consortia therapeutics with an excellent safety profile and disease-modifying potential. The Company’s unique manufacturing technology allows to produce bacterial consortia as a single Drug Substance, resulting in a highly cost-effective and scalable manufacturing route. The diverse pipeline of MRM Health includes therapeutic programs for inflammatory bowel diseases, CNS disorders, metabolic diseases and auto-immune diseases.
Designed for efficacy, developed for synergy, produced as one.
Contact us